Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

Clinical trial NCT06154408 · COMPLETED

Trial details

NCT number: NCT06154408
Sponsor: S.LAB (SOLOWAYS)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

LDL Hyperlipoproteinemia Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia Triglyceride Storage Type I or II Disease

Start date: 2022-02-10
Primary completion: 2022-07-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.